Developmental transcription factor NFIB is a putative target of oncofetal miRNAs and is associated with tumour aggressiveness in lung adenocarcinoma

Genes involved in fetal lung development are thought to play crucial roles in the malignant transformation of adult lung cells. Consequently, the study of lung tumour biology in the context of lung development has the potential to reveal key developmentally relevant genes that play critical roles in lung cancer initiation/progression. Here, we describe for the first time a comprehensive characterization of miRNA expression in human fetal lung tissue, with subsequent identification of 37 miRNAs in non‐small cell lung cancer (NSCLC) that recapitulate their fetal expression patterns. Nuclear factor I/B (NFIB), a transcription factor essential for lung development, was identified as a potential frequent target for these ‘oncofetal’ miRNAs. Concordantly, analysis of NFIB expression in multiple NSCLC independent cohorts revealed its recurrent underexpression (in ∼40–70% of tumours). Interrogation of NFIB copy number, methylation, and mutation status revealed that DNA level disruption of this gene is rare, and further supports the notion that oncofetal miRNAs are likely the primary mechanism responsible for NFIB underexpression in NSCLC. Reflecting its functional role in regulating lung differentiation, low expression of NFIB was significantly associated with biologically more aggressive subtypes and, ultimately, poorer survival in lung adenocarcinoma patients. Copyright © 2016 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

[1]  S. Ingvarsson,et al.  Quantitative Analysis of miRNA Expression in Seven Human Foetal and Adult Organs , 2011, PloS one.

[2]  Igor Jurisica,et al.  NAViGaTOR: Network Analysis, Visualization and Graphing Toronto , 2009, Bioinform..

[3]  A. Regev,et al.  SOX2 Is an Amplified Lineage Survival Oncogene in Lung and Esophageal Squamous Cell Carcinomas , 2009, Nature Genetics.

[4]  Derek Y. Chiang,et al.  Characterizing the cancer genome in lung adenocarcinoma , 2007, Nature.

[5]  Derek Y. Chiang,et al.  Suppression of Lung Adenocarcinoma Progression by Nkx2-1 , 2011, Nature.

[6]  William C Hahn,et al.  Integrated cistromic and expression analysis of amplified NKX2-1 in lung adenocarcinoma identifies LMO3 as a functional transcriptional target. , 2013, Genes & development.

[7]  M. Dean.  Cancer as a complex developmental disorder--nineteenth Cornelius P. Rhoads Memorial Award Lecture. , 1998, Cancer Research.

[8]  Levi Garraway,et al.  Nuclear factor I/B is an oncogene in small cell lung cancer. , 2011, Genes & development.

[9]  Xiaoming Liu,et al.  The Role of Sox Genes in Lung Morphogenesis and Cancer , 2012, International journal of molecular sciences.

[10]  Igor Jurisica,et al.  Gene expression–based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study , 2008, Nature Medicine.

[11]  D. Mu,et al.  Genetic similarities between organogenesis and tumorigenesis of the lung , 2008, Cell cycle.

[12]  Song Liu,et al.  Mesenchymal nuclear factor I B regulates cell proliferation and epithelial differentiation during lung maturation. , 2011, Developmental biology.

[13]  Yuzhuo Wang,et al.  Integrin-linked kinase as a target for ERG-mediated invasive properties in prostate cancer models. , 2012, Carcinogenesis.

[14]  T. Dønnem,et al.  MicroRNA Signatures in Tumor Tissue Related to Angiogenesis in Non-Small Cell Lung Cancer , 2012, PloS one.

[15]  Igor Jurisica,et al.  Smoking status impacts microRNA mediated prognosis and lung adenocarcinoma biology , 2014, BMC Cancer.

[16]  S. Knudsen,et al.  Evaluation of microRNA expression profiles that may predict recurrence of localized stage I non-small cell lung cancer after surgical resection. , 2010, Cancer research.

[17]  Yang Xue-ning.  International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma , 2011 .

[18]  D. Warburton,et al.  Lung organogenesis. , 2010, Current topics in developmental biology.

[19]  Feng Jiang,et al.  Early detection of lung adenocarcinoma in sputum by a panel of microRNA markers , 2010, International journal of cancer.

[20]  Mariarosaria Incoronato,et al.  miR-212 increases tumor necrosis factor-related apoptosis-inducing ligand sensitivity in non-small cell lung cancer by targeting the antiapoptotic protein PED. , 2010, Cancer research.

[21]  Takeshi Nagayasu,et al.  Kras(G12D) and Nkx2-1 haploinsufficiency induce mucinous adenocarcinoma of the lung. , 2012, The Journal of clinical investigation.

[22]  David R. Kelley,et al.  Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks , 2012, Nature Protocols.

[23]  Xi Chen,et al.  Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  Mark M Perry,et al.  Maternally imprinted microRNAs are differentially expressed during mouse and human lung development , 2007, Developmental dynamics : an official publication of the American Association of Anatomists.

[25]  EYA4 is inactivated biallelically at a high frequency in sporadic lung cancer and is associated with familial lung cancer risk , 2013, Oncogene.

[26]  Masahiro Tsuboi,et al.  International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma , 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[27]  miRNA regulated pathways in late stage murine lung development , 2013, BMC Developmental Biology.

[28]  Steven J. M. Jones,et al.  Comprehensive molecular portraits of human breast tumours , 2013 .

[29]  I. Jurisica,et al.  Lung cancer: Developmental networks gone awry? , 2009, Cancer biology & therapy.

[30]  Danish Sayed,et al.  MicroRNAs in development and disease. , 2011, Physiological reviews.

[31]  Yun Lu,et al.  Evidence for type II cells as cells of origin of K-Ras–induced distal lung adenocarcinoma , 2012, Proceedings of the National Academy of Sciences.

[32]  Richard Durbin,et al.  Fast and accurate long-read alignment with Burrows–Wheeler transform , 2010, Bioinform..

[33]  Jan Budczies,et al.  Online Survival Analysis Software to Assess the Prognostic Value of Biomarkers Using Transcriptomic Data in Non-Small-Cell Lung Cancer , 2013, PloS one.

[34]  R. Yuen,et al.  Extensive epigenetic reprogramming in human somatic tissues between fetus and adult , 2011, Epigenetics & Chromatin.

[35]  Akihiko Yoshizawa,et al.  Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases , 2011, Modern Pathology.

[36]  John Quackenbush,et al.  Genesis: cluster analysis of microarray data , 2002, Bioinform..

[37]  C. Croce,et al.  Insulin growth factor signaling is regulated by microRNA-486, an underexpressed microRNA in lung cancer , 2013, Proceedings of the National Academy of Sciences.

[38]  A. E. Sippel,et al.  Nuclear factor I-B (Nfib) deficient mice have severe lung hypoplasia , 2002, Mechanisms of Development.

[39]  S. Lam,et al.  miR-101 DNA Copy Loss is a Prominent Subtype Specific Event in Lung Cancer , 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[40]  I. Jurisica,et al.  NAViGaTing the Micronome – Using Multiple MicroRNA Prediction Databases to Identify Signalling Pathway-Associated MicroRNAs , 2011, PloS one.

[41]  Igor Jurisica,et al.  Interaction Techniques for Selecting and Manipulating Subgraphs in Network Visualizations , 2009, IEEE Transactions on Visualization and Computer Graphics.

[42]  Marta Di Nicola,et al.  microRNAs Derived from Circulating Exosomes as Noninvasive Biomarkers for Screening and Diagnosing Lung Cancer , 2013, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[43]  Mo-Fang Liu,et al.  IL-1β-mediated repression of microRNA-101 is crucial for inflammation-promoted lung tumorigenesis. , 2014, Cancer research.

[44]  S. Lam,et al.  Lung Adenocarcinoma of Never Smokers and Smokers Harbor Differential Regions of Genetic Alteration and Exhibit Different Levels of Genomic Instability , 2012, PloS one.

[45]  Yang Wang,et al.  Microrna-127 Modulates Fetal Lung Development , 2008 .

[46]  Steven J. M. Jones,et al.  Comprehensive molecular portraits of human breast tumors , 2012, Nature.

[47]  L. Richards,et al.  The Transcription Factor Gene Nfib Is Essential for both Lung Maturation and Brain Development , 2005, Molecular and Cellular Biology.